Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?

ABSTRACT:

SUBMITTER: Babaier A 

PROVIDER: S-EPMC10477662 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature